Changing respiratory health forever

RESPINOR is developing a novel, non-invasive, ultrasound-based medical device for continuous diaphragm monitoring, the main breathing muscle. RESPINOR’s technology is the winner of Horizon 2020 funding both in phase I and II. The company has successfully completed clinical feasibility studies in Europe for the first target segment mechanical ventilation (MV) with technical proof of principle and proof of concept confirmed. Our technology has a broad range of potential benefits and represents a technology platform for applications in critical care and other areas of respiratory medicine.

Latest news

1. April 2022

RESPINOR is strengthening the team preparing for commercialization of DXT

15. October 2021

RESPINOR AS Successfully completed Private Placement of approx. NOK 20 million (€ 2,0 million)

18. June 2021

RESPINOR has started the last phase of the clinical program, DE-RISK-WF study in Europe, with DXT before regulatory submission (EU and USA)

22. April 2021

Interview: The winners of the NLSInvest Rising Star Award

20. April 2021

RESPINOR Announced Winner at the Nordic Life Science Investment Days

23. March 2021

Kitron and RESPINOR in MedTech partnership

11. December 2020

RESPINOR awarded 14.2M NOKs from the Research Council of Norway

4. May 2020

RESPINOR winner of the European Innovation Councils (EIC) ePitching event for COVID-19 solutions

6. March 2020

RESPINOR made Deloitte’s Technology Fast 50 list

21. June 2019

RESPINOR featured in Kapital magazine – Norway’s biggest financial magazine

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 768260.

For patients with chronic respiratory diseases as well as in critical settings, there is a clear need for a non-invasive ultrasound tool to better characterize diaphragm muscle weakness.

EU Eurostars evaluator comment

Quality Policy:
RESPINOR develops innovative products for monitoring of respiratory function. RESPINOR is dedicated to provide uncompromised quality products that are safe and cost-effective to health care systems.
We understand that listening to customer needs and meeting market needs are key to continued product improvement.
RESPINOR is committed to maintaining an effective quality management system compliant with all applicable regulations in countries where our products are developed, manufactured and sold.